The domestic healthcare sector is expected to see stronger growth over the next three years supported by new drug launches, while earnings from the US generics business are likely to remain flat for most companies, according to a report by Systematix Research.
In India, the launch of generic semaglutide, expected in the first quarter of FY27, is projected to boost overall Indian Pharmaceutical Market (IPM) growth by 0.5-1%. Prices are anticipated to be 30-50% lower than current levels initially, with the potential for deeper cuts of up to 70-75% o
New Delhi [India], November 14: Akums Drugs & Pharmaceuticals Ltd., India's Largest Contract Development and Manufacturing Organizations (CDMO), announced its financial results for the second quarter of FY26.
Mumbai (Maharashtra) [India] Aug 7 (ANI/PRNewswire): Alembic Pharmaceuticals, a Vadodara headquartered company, is a leading manufacturer of pharmaceuticals with three business verticals -International generics (approximately 58 per cent), Domestic branded formulations (approximately 31 per
New Delhi, July 28 (ANI- Business Wire India): Biocon branded formulations business announced the launch of a new patient support program 'Ek Prayaas' through a nationwide awareness drive for Hepatitis C on the occasion of 'World Hepatitis Day' on July 28th.